Back
Spero Therapeutics Stock Price Chart
Sponsored
SPRO
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15
SPRO
Spero Therapeutics
Last Price:
1.18
Seasonality Move:
7.16%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRO is experiencing selling pressure, which indicates risk of future bearish movement.
Spero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.2 | Sell |
20-day SMA: | 1.25 | Sell |
50-day SMA: | 1.28 | Sell |
200-day SMA: | 1.43 | Sell |
8-day EMA: | 1.2 | Sell |
20-day EMA: | 1.24 | Sell |
50-day EMA: | 1.27 | Sell |
200-day EMA: | 1.38 | Sell |
Spero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 38.15 | Sell |
Chaikin Money Flow: | -217293 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.2 - 1.32) | Sell |
Bollinger Bands (100): | (1.24 - 1.38) | Sell |
Spero Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spero Therapeutics Stock
Is Spero Therapeutics Stock a Buy?
- Spero Therapeutics share price is 1.16 while SPRO 8-day simple moving average is 1.20, which is a Sell signal.
- The stock price of SPRO is 1.16 while Spero Therapeutics 20-day SMA is 1.25, which makes it a Sell.
- Spero Therapeutics 50-day simple moving average is 1.28 while SPRO share price is 1.16, making it a Sell technically.
- SPRO stock price is 1.16 and Spero Therapeutics 200-day simple moving average is 1.43, creating a Sell signal.
SPRO Technical Analysis vs Fundamental Analysis
Sell
15
Spero Therapeutics (SPRO)
is a Sell
Is Spero Therapeutics a Buy or a Sell?
-
Spero Therapeutics stock is rated a Sell
The current Spero Therapeutics [SPRO] share price is $1.16. The Score for SPRO is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Spero Therapeutics Stock Info
Market Cap:
63.24M
Price in USD:
1.16
Share Volume:
391.13K
Spero Therapeutics 52-Week Range
52-Week High:
1.89
52-Week Low:
1.01
Sell
15
Spero Therapeutics (SPRO)
is a Sell
Spero Therapeutics Share Price Forecast
-
What is the Spero Therapeutics stock price today?
The Spero Therapeutics stock price is 1.16 USD today. -
Will SPRO stock go up or go down?
Spero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Spero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spero Therapeutics is overvalued.
Is Spero Therapeutics Stock a Buy?
- Spero Therapeutics share price is 1.16 while SPRO 8-day exponential moving average is 1.20, which is a Sell signal.
- The stock price of SPRO is 1.16 while Spero Therapeutics 20-day EMA is 1.24, which makes it a Sell.
- Spero Therapeutics 50-day exponential moving average is 1.27 while SPRO share price is 1.16, making it a Sell technically.
- SPRO stock price is 1.16 and Spero Therapeutics 200-day simple moving average is 1.38, creating a Sell signal.
Fundamental Analysis of Spero Therapeutics
Is Spero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and an increase next year of $0.58 per share.
Technical Analysis of Spero Therapeutics
Should I short Spero Therapeutics stock?
- SPRO Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Spero Therapeutics is a Sell
- Spero Therapeutics Relative Strength Index (RSI) is 38.15, which suggest Spero Therapeutics is oversold
- The Bollinger Bands (25) for Spero Therapeutics is (1.2 - 1.32), which suggest Spero Therapeutics is a Sell
- The Bollinger Bands (100) for Spero Therapeutics is (1.24 - 1.38), which suggest Spero Therapeutics is a Sell
* Spero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.